Skip to main content
Top
Published in: AIDS and Behavior 4/2014

01-04-2014 | Commentary

Moving the Bar to the Right Place: Positioning Interventions in HIV Prevention

Authors: Beryl A. Koblin, Gordon Mansergh, Margaret Chesney, Thomas Coates

Published in: AIDS and Behavior | Issue 4/2014

Login to get access

Excerpt

In their article titled “Setting the Bar High or Setting Up to Fail?: Interpretations and Implications of the EXPLORE Study”, Kalichman et al. [1] discuss the positive and negative interpretations in the research literature about the effectiveness of the EXPLORE behavioral intervention in reducing HIV incidence. They conclude that the preponderance of negative interpretations has had a consequential negative impact on policy decisions about the role of behavioral counseling in HIV prevention in the United States (US). Kalichman et al. [1] go on to discuss that the 35 % benchmark for a reduction in HIV incidence in the EXPLORE Study was “setting the bar too high.” We believe that while the role of behavioral counseling is critical for HIV prevention, the HIV prevention intervention “bar” needs to move to a different location altogether. …
Literature
1.
go back to reference Kalichman SC, Zohren L, Easton LA. Setting the bar high or setting up to fail: interpretations and implications of the EXPLORE Study (HPTN 015). AIDS Behav. 2013. doi:10.1007/s10461-013-0603-0. Kalichman SC, Zohren L, Easton LA. Setting the bar high or setting up to fail: interpretations and implications of the EXPLORE Study (HPTN 015). AIDS Behav. 2013. doi:10.​1007/​s10461-013-0603-0.
2.
go back to reference Koblin B, Chesney M, Coates T, Team ES. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364(9428):41–50.PubMedCrossRef Koblin B, Chesney M, Coates T, Team ES. Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet. 2004;364(9428):41–50.PubMedCrossRef
3.
go back to reference Coates TJ. An expanded behavioral paradigm for prevention and treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2013;63(Suppl 2):S179–82.PubMedCrossRef Coates TJ. An expanded behavioral paradigm for prevention and treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2013;63(Suppl 2):S179–82.PubMedCrossRef
4.
go back to reference Johnson BT, Scott-Sheldon LA, Smoak ND, Lacroix JM, Anderson JR, Carey MP. Behavioral interventions for African Americans to reduce sexual risk of HIV: a meta-analysis of randomized controlled trials. J Acquir Immune Defic Syndr. 2009;51(4):492–501.PubMedCentralPubMedCrossRef Johnson BT, Scott-Sheldon LA, Smoak ND, Lacroix JM, Anderson JR, Carey MP. Behavioral interventions for African Americans to reduce sexual risk of HIV: a meta-analysis of randomized controlled trials. J Acquir Immune Defic Syndr. 2009;51(4):492–501.PubMedCentralPubMedCrossRef
5.
go back to reference Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, et al. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev. 2008;3:CD001230.PubMed Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, et al. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev. 2008;3:CD001230.PubMed
6.
go back to reference Scott-Sheldon LA, Huedo-Medina TB, Warren MR, Johnson BT, Carey MP. Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010. J Acquir Immune Defic Syndr. 2011;58(5):489–98.PubMedCrossRef Scott-Sheldon LA, Huedo-Medina TB, Warren MR, Johnson BT, Carey MP. Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010. J Acquir Immune Defic Syndr. 2011;58(5):489–98.PubMedCrossRef
7.
go back to reference Henny KD, Crepaz N, Lyles CM, Marshall KJ, Aupont LW, Jacobs ED, et al. Efficacy of HIV/STI behavioral interventions for heterosexual African American men in the United States: a meta-analysis. AIDS Behav. 2012;16(5):1092–114.PubMedCrossRef Henny KD, Crepaz N, Lyles CM, Marshall KJ, Aupont LW, Jacobs ED, et al. Efficacy of HIV/STI behavioral interventions for heterosexual African American men in the United States: a meta-analysis. AIDS Behav. 2012;16(5):1092–114.PubMedCrossRef
8.
go back to reference Scott-Sheldon LA, Fielder RL, Carey MP. Sexual risk reduction interventions for patients attending sexually transmitted disease clinics in the United States: a meta-analytic review, 1986 to early 2009. Ann Behav Med. 2010;40(2):191–204.PubMedCentralPubMedCrossRef Scott-Sheldon LA, Fielder RL, Carey MP. Sexual risk reduction interventions for patients attending sexually transmitted disease clinics in the United States: a meta-analytic review, 1986 to early 2009. Ann Behav Med. 2010;40(2):191–204.PubMedCentralPubMedCrossRef
9.
go back to reference Crepaz N, Marshall KJ, Aupont LW, Jacobs ED, Mizuno Y, Kay LS, et al. The efficacy of HIV/STI behavioral interventions for African American females in the United States: a meta-analysis. Am J Public Health. 2009;99(11):2069–78.PubMedCentralPubMedCrossRef Crepaz N, Marshall KJ, Aupont LW, Jacobs ED, Mizuno Y, Kay LS, et al. The efficacy of HIV/STI behavioral interventions for African American females in the United States: a meta-analysis. Am J Public Health. 2009;99(11):2069–78.PubMedCentralPubMedCrossRef
10.
go back to reference Darbes L, Crepaz N, Lyles C, Kennedy G, Rutherford G. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. AIDS. 2008;22(10):1177–94.PubMedCentralPubMedCrossRef Darbes L, Crepaz N, Lyles C, Kennedy G, Rutherford G. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans. AIDS. 2008;22(10):1177–94.PubMedCentralPubMedCrossRef
11.
go back to reference Bornstein M, Rothstein HR, Hedges LV, Higgens JPT. Introduction to Meta-Analysis. Chichester: Wiley; 2009.CrossRef Bornstein M, Rothstein HR, Hedges LV, Higgens JPT. Introduction to Meta-Analysis. Chichester: Wiley; 2009.CrossRef
12.
go back to reference The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. 2010. The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. 2010.
14.
go back to reference Wagenaar BH, Christiansen-Lindquist L, Khosropour C, Salazar LF, Benbow N, Prachand N, et al. Willingness of US men who have sex with men (MSM) to participate in couples HIV voluntary counseling and testing (CVCT). PloS one. 2012;7(8):e42953.PubMedCentralPubMedCrossRef Wagenaar BH, Christiansen-Lindquist L, Khosropour C, Salazar LF, Benbow N, Prachand N, et al. Willingness of US men who have sex with men (MSM) to participate in couples HIV voluntary counseling and testing (CVCT). PloS one. 2012;7(8):e42953.PubMedCentralPubMedCrossRef
15.
go back to reference Stephenson R, Sullivan PS, Salazar LF, Gratzer B, Allen S, Seelbach E. Attitudes towards couples-based HIV testing among MSM in three US cities. AIDS Behav. 2011;15(Suppl 1):S80–7.PubMedCentralPubMedCrossRef Stephenson R, Sullivan PS, Salazar LF, Gratzer B, Allen S, Seelbach E. Attitudes towards couples-based HIV testing among MSM in three US cities. AIDS Behav. 2011;15(Suppl 1):S80–7.PubMedCentralPubMedCrossRef
16.
go back to reference Wei C, Herrick A, Raymond HF, Anglemyer A, Gerbase A, Noar SM. Social marketing interventions to increase HIV/STI testing uptake among men who have sex with men and male-to-female transgender women. Cochrane Database Syst Rev. 2011;9:CD009337.PubMed Wei C, Herrick A, Raymond HF, Anglemyer A, Gerbase A, Noar SM. Social marketing interventions to increase HIV/STI testing uptake among men who have sex with men and male-to-female transgender women. Cochrane Database Syst Rev. 2011;9:CD009337.PubMed
17.
go back to reference Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedCentralPubMedCrossRef Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedCentralPubMedCrossRef
18.
go back to reference Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.PubMedCentralPubMedCrossRef Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.PubMedCentralPubMedCrossRef
19.
go back to reference Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90.PubMedCrossRef Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90.PubMedCrossRef
20.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCentralPubMedCrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCentralPubMedCrossRef
21.
go back to reference Smith D, Herbst J, Zhang X, Rose C. Condom efficacy by consistency of use among MSM: US. 20th conference on retroviruses and opportunistic infections. Atlanta; 3–6 March 2013. Smith D, Herbst J, Zhang X, Rose C. Condom efficacy by consistency of use among MSM: US. 20th conference on retroviruses and opportunistic infections. Atlanta; 3–6 March 2013.
22.
go back to reference Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.PubMedCentralPubMedCrossRef Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.PubMedCentralPubMedCrossRef
23.
go back to reference Marrazzo J, Ramjee G, Nair G. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine or vaginal tenofovir gel in the VOICE study (MTN 003). 20th conference on retroviruses and opportunistic infections. Atlanta; 3–6 March 2013. p. Abstract 26LB. Marrazzo J, Ramjee G, Nair G. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine or vaginal tenofovir gel in the VOICE study (MTN 003). 20th conference on retroviruses and opportunistic infections. Atlanta; 3–6 March 2013. p. Abstract 26LB.
24.
go back to reference Koblin BA, Andrasik M, Austin J. Preparing for the unexpected: the pivotal role of social and behavioral sciences in trials of biomedical HIV prevention interventions. J Acquir Immune Defic Syndr. 2013;63(Suppl 2):S183–6.PubMedCrossRef Koblin BA, Andrasik M, Austin J. Preparing for the unexpected: the pivotal role of social and behavioral sciences in trials of biomedical HIV prevention interventions. J Acquir Immune Defic Syndr. 2013;63(Suppl 2):S183–6.PubMedCrossRef
25.
go back to reference Lau CY, Swann EM, Singh S, Kafaar Z, Meissner HI, Stansbury JP. Conceptual framework for behavioral and social science in HIV vaccine clinical research. Vaccine. 2011;29(44):7794–800.PubMedCentralPubMedCrossRef Lau CY, Swann EM, Singh S, Kafaar Z, Meissner HI, Stansbury JP. Conceptual framework for behavioral and social science in HIV vaccine clinical research. Vaccine. 2011;29(44):7794–800.PubMedCentralPubMedCrossRef
27.
go back to reference Aral SO, Blanchard J. Biomedical and social dimensions of HIV prevention. Am J Public Health. 2012;102(9):e9 author reply e-10.PubMedCrossRef Aral SO, Blanchard J. Biomedical and social dimensions of HIV prevention. Am J Public Health. 2012;102(9):e9 author reply e-10.PubMedCrossRef
28.
go back to reference Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, et al. Continuum of HIV care: differences in care and treatment by sex and race/ethnicity in the United States. In: XIX International AIDS conferences, Washington, DC, 22–27 July 2012. Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, et al. Continuum of HIV care: differences in care and treatment by sex and race/ethnicity in the United States. In: XIX International AIDS conferences, Washington, DC, 22–27 July 2012.
29.
go back to reference Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013. doi:10.1093/cid/cit420. Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. Clin Infect Dis. 2013. doi:10.​1093/​cid/​cit420.
Metadata
Title
Moving the Bar to the Right Place: Positioning Interventions in HIV Prevention
Authors
Beryl A. Koblin
Gordon Mansergh
Margaret Chesney
Thomas Coates
Publication date
01-04-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0607-9

Other articles of this Issue 4/2014

AIDS and Behavior 4/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.